Regarding the matched group, TRβ remained to be predictive for advanced overall survival in BRCA1 associated cases (p = 0.018), while survival rates of TRβ positive vs. negative cases did not differ among sporadic breast cancers. This evidence concerns the gene BRCA1 and breast carcinoma.